Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.

Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, Perrone F, Tamborini E, Gloghini A, Arienti F, Vergani B, Deho P, De Cecco L, Vallacchi V, Frati P, Shahaj E, Villa A, Santinami M, De Braud F, Rivoltini L, Rodolfo M
Oncotarget. 2016 Jan 26;7(4):4428-41. doi: 10.18632/oncotarget.6599. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.